These data suggest that, under specific therapeutic circumstances that induce NF-kB function, an immunomodulatory effect could be achieved, thereby increasing the susceptibility of NB cells to NK-cell-mediated killing, thus representing a novel approach aimed at supporting the NK-cell-mediated immunotherapy of NB. Here, NFKB1 is linked to neuroblastoma.